Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Beclomethasone + Prednisone for GI GVHD
NCT00043147Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in graft-versus-host disease (GVHD), sponsored by Memorial Sloan Kettering Cancer Center. Started Apr 2002; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00043147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043147.